Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

KDNY

Chinook Therapeutics (KDNY)

Chinook Therapeutics Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:KDNY
일자시간출처헤드라인심볼기업
2023/11/2306:15Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:KDNYChinook Therapeutics Inc
2023/08/2202:21Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:KDNYChinook Therapeutics Inc
2023/08/1713:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:KDNYChinook Therapeutics Inc
2023/08/1206:02Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:KDNYChinook Therapeutics Inc
2023/08/1206:00Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:KDNYChinook Therapeutics Inc
2023/08/1205:58Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:KDNYChinook Therapeutics Inc
2023/08/1205:56Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:KDNYChinook Therapeutics Inc
2023/08/1205:54Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:KDNYChinook Therapeutics Inc
2023/08/1205:52Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:KDNYChinook Therapeutics Inc
2023/08/1205:50Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:KDNYChinook Therapeutics Inc
2023/08/1205:48Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:KDNYChinook Therapeutics Inc
2023/08/1205:46Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:KDNYChinook Therapeutics Inc
2023/08/1205:44Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:KDNYChinook Therapeutics Inc
2023/08/1205:42Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:KDNYChinook Therapeutics Inc
2023/08/1205:39Edgar (US Regulatory)Form POSASR - Post-effective Amendment to an automatic shelf registration statementNASDAQ:KDNYChinook Therapeutics Inc
2023/08/1205:35Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:KDNYChinook Therapeutics Inc
2023/08/1205:31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KDNYChinook Therapeutics Inc
2023/08/1205:11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KDNYChinook Therapeutics Inc
2023/08/1205:11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KDNYChinook Therapeutics Inc
2023/08/1205:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KDNYChinook Therapeutics Inc
2023/08/1205:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KDNYChinook Therapeutics Inc
2023/08/1205:09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KDNYChinook Therapeutics Inc
2023/08/1205:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KDNYChinook Therapeutics Inc
2023/08/1205:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KDNYChinook Therapeutics Inc
2023/08/1205:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KDNYChinook Therapeutics Inc
2023/08/0805:05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:KDNYChinook Therapeutics Inc
2023/08/0405:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KDNYChinook Therapeutics Inc
2023/08/0208:27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KDNYChinook Therapeutics Inc
2023/08/0120:05Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:KDNYChinook Therapeutics Inc
2023/07/2821:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KDNYChinook Therapeutics Inc
 검색 관련기사 보기:NASDAQ:KDNY